Economy, business, innovation

April 2026

Trump’s Broken Brain Is Trying To Fool America With Iran War Hallucinations

Trump is claiming that he has this fantastic deal to end the Iran war, but the problem is that the only agreement that has been reached is that the Strait of Hormuz will be open for as long as the ceasefire between Israel and Lebanon continues. Negotiators are hopeful that an agreement can be reached […]

Trump’s Broken Brain Is Trying To Fool America With Iran War Hallucinations Read More »

Why Albemarle Is Dropping 9.0%?

ALB Price $196.16 Change -9.0% Volume 1.8M Albemarle Corporation (NYSE: ALB) plunged 9.0% on Friday, trading at $196.16 as Baird shifted its stance to Neutral on the specialty chemicals maker. The $23.1 billion company saw elevated trading activity with 1.8M shares changing hands as the analyst action pressured shares lower. Baird changed its rating to

Why Albemarle Is Dropping 9.0%? Read More »

Onto Innovation Jumps 7.9% After Evercore ISI Group Main to Outperform

ONTO Price $288.30 Change +7.9% Volume 422,825 Onto Innovation Inc. soared 7.9% to $288.30 on Friday as three Wall Street firms unleashed a wave of analyst upgrades and price target increases, with an average new target of $325 reflecting growing confidence in the semiconductor equipment maker’s prospects. The surge followed a coordinated show of bullishness

Onto Innovation Jumps 7.9% After Evercore ISI Group Main to Outperform Read More »

Why Netflix Is Dropping 9.8%: Barclays Main to Equal-Weight

NFLX Price $97.18 Change -9.8% Volume 53.1M Netflix shares tumbled 9.8% on Friday, closing at $97.18, after three Wall Street firms slashed their price targets on the streaming giant in a coordinated wave of downgrades. The sell-off erased billions in market value as the company’s $413.4B market capitalization came under pressure from fresh analyst skepticism.

Why Netflix Is Dropping 9.8%: Barclays Main to Equal-Weight Read More »

Hims & Hers Health Jumps 8.7% After B of A Securities Main to Neutral

HIMS Price $29.32 Change +8.7% Volume 22.8M Hims & Hers Health surged 8.7% Friday to $29.32 after Bank of America Securities boosted its price target by 19.0%, signaling growing confidence in the telehealth platform’s growth trajectory. The upgrade fueled momentum. B of A Securities maintained its Neutral rating but raised its price target from $21

Hims & Hers Health Jumps 8.7% After B of A Securities Main to Neutral Read More »

Scroll to Top